158 related articles for article (PubMed ID: 8323768)
1. Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy.
Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
Acta Oncol; 1993; 32(3):307-10. PubMed ID: 8323768
[TBL] [Abstract][Full Text] [Related]
2. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.
Gundersen S; Lote K; Watne K
Eur J Cancer; 1998 Sep; 34(10):1565-9. PubMed ID: 9893629
[TBL] [Abstract][Full Text] [Related]
4. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
5. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
[TBL] [Abstract][Full Text] [Related]
6. Combined intra-arterial chemotherapy and irradiation of malignant gliomas.
Watne K; Nome O; Hager B; Hirschberg H
Acta Oncol; 1991; 30(7):835-41. PubMed ID: 1662522
[TBL] [Abstract][Full Text] [Related]
7. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
8. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
9. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
Neurosurgery; 1992 Feb; 30(2):223-7. PubMed ID: 1312230
[TBL] [Abstract][Full Text] [Related]
10. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
11. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
13. Combined intraarterial and systemic chemotherapy for intracerebral tumors.
Stewart DJ; Grahovac Z; Hugenholtz H; Russell N; Richard M; Benoit B
Neurosurgery; 1987 Aug; 21(2):207-14. PubMed ID: 2443873
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
[TBL] [Abstract][Full Text] [Related]
15. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
Prados MD; Scott C; Curran WJ; Nelson DF; Leibel S; Kramer S
J Clin Oncol; 1999 Nov; 17(11):3389-95. PubMed ID: 10550132
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
Watne K; Hager B
J Neurooncol; 1987; 5(1):47-50. PubMed ID: 3598620
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors.
Comella G; Scoppa G; De Marco M; Ianniello GP; Melillo G; Coucourde F; Zarrilli D
J Neurooncol; 1985; 3(1):13-7. PubMed ID: 2987423
[TBL] [Abstract][Full Text] [Related]
18. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
Buckner JC; Schomberg PJ; McGinnis WL; Cascino TL; Scheithauer BW; O'Fallon JR; Morton RF; Kuross SA; Mailliard JA; Hatfield AK; Cole JT; Steen PD; Bernath AM
Cancer; 2001 Jul; 92(2):420-33. PubMed ID: 11466698
[TBL] [Abstract][Full Text] [Related]
19. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Burch PA; Schaefer PL; Dinapoli RP; Novotny PJ; Scheithauer BW; Rowland KM; Vukov AM; Mailliard JA; Morton RF
J Clin Oncol; 1998 Sep; 16(9):2953-8. PubMed ID: 9738563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]